Evidence map›Paper›PMID 42630708›Full record

ArticleOncology research2026

Combinatorial Effects of Plasma-Treated Solution and Plasma-Treated Hydrogel with Cisplatin in Vulvar Cancer Cells.

Estelle C I D Schad, Janet P Raja Xavier, Hortense Decool, Marcel Arnholdt, Franziska Keßler, Jan Schöttke, Sara Y Brucker, Ernst Oberlechner, Johanna Laupp, Martin Weiss

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncology research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Estelle C I D SchadDepartment of Women's Health Tübingen, University of Tübingen, Tübingen, Germany.
Janet P Raja XavierDepartment of Women's Health Tübingen, University of Tübingen, Tübingen, Germany.
Hortense DecoolDepartment of Women's Health Tübingen, University of Tübingen, Tübingen, Germany.
Marcel ArnholdtDepartment of Women's Health Tübingen, University of Tübingen, Tübingen, Germany.
Franziska KeßlerDepartment of Women's Health Tübingen, University of Tübingen, Tübingen, Germany.
Jan SchöttkeDepartment of Women's Health Tübingen, University of Tübingen, Tübingen, Germany.
Sara Y BruckerDepartment of Women's Health Tübingen, University of Tübingen, Tübingen, Germany.
Ernst OberlechnerDepartment of Women's Health Tübingen, University of Tübingen, Tübingen, Germany.
Johanna LauppDepartment of Women's Health Tübingen, University of Tübingen, Tübingen, Germany.
Martin WeissDepartment of Women's Health Tübingen, University of Tübingen, Tübingen, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antineoplastic AgentsCarcinoma, Squamous CellCisplatinHydrogelsPlasma GasesVulvar NeoplasmsApoptosisCell Line, TumorCell SurvivalFemaleHumansReactive Oxygen SpeciesAntineoplastic AgentsCisplatinHydrogelsPlasma GasesReactive Oxygen Speciescold atmospheric plasma (CAP)combination therapylow-thermal argon plasma devitalization (ltAPD)non-invasive physical plasma (NIPP)reactive oxygen and nitrogen speciesVulvar squamous cell carcinoma

Identifiers

PMID42630708
PMCPMC13494491

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.